He passed Dale Earnhardt Jr. in merchandise sales—a remarkable feat considering Earnhardt’s legacy and loyal spectators.
John Schwarb13 min read
With thousands of medical success stories and billions in revenue, officials at Lilly are still celebrating the success of Zyprexa. But its troubled path reveals volumes about how difficult bringing even an approved medication to market can turn out to be.
Evan West28 min read
When We Build It, Will They Come?
The Indianapolis Colts, a winning team on the field, would not be financially viable in the modern NFL if they had to spend another two decades in the Hoosier Dome.